40 matches for your search in the start-up spotlight

rss
matching the following criteria

image description
RocketVax AG

The company brings together both scientific and operational expertise from various institutions in Switzerland and Germany and aims to become a world leading centre of excellence for novel vaccine development. RocketVax has its foundation in the ties between Swiss Rockets AG, a Swiss incubator ...

more

image description
PAGE Therapeutics

We are a platform-based oncology drug development company focused on the discovery, development and commercialization of innovative compounds that prevent metastasis. Our goal is to improve the quality of life and to prolong the life of patients living with cancer.

more

image description
Bright Peak Therapeutics

Bright Peak is a privately held biotechnology company based in San Diego, CA and Basel, Switzerland developing innovative cytokine therapeutics that are uniquely engineered to precisely tune and control desired biological properties. Using its proprietary Enhanced Design and Combine (EDC) ...

more

image description
NextImmune AG

NextImmune focuses on the research and development of a new generation of immunosuppressive drugs for autoimmune diseases and Organ Transplantation - with objectives of high efficacy, good safety without adverse effects as known from conventional immunosuppressants.

more

image description
Selmod GmbH

Selmod is a Swiss biotech start-up and was founded in May 2016 in Basel, Switzerland. Selmod develops innovative antibiotics for the treatment of life-threatening, multi-drug resistant infections. The company’s focus is on discovery and early clinical development of small molecules and peptides ...

more

image description
Engimmune Therapeutics AG

Engineering next-generation T cell receptor therapies

more

image description
Cimeio Therapeutics AG

We are an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs™ for patients with debilitating and life-threatening diseases. Our proprietary technology platform is based on the discovery of novel protein variants, which when ...

more

image description
SEAL Therapeutics AG

SEAL Therapeutics is developing its proprietary SEAL technology as a potential gene therapy for laminin-α2 deficient congenital muscular dystrophy (LAMA2 MD), a severe and progressive neuromuscular disease affecting children from birth. SEAL Therapeutics aims to team-up with and support a ...

more

image description
Pattern BioSciences AG

Pattern BioSciences is a biotechnology start-up company and an ETH Zurich spin-off. The company develops programmable therapies using gene circuit technologies.

more

image description
Bright Peak Therapeutics

Bright Peak is a privately held biotechnology company based in San Diego, CA and Basel, Switzerland developing innovative cytokine therapeutics that are uniquely engineered to precisely tune and control desired biological properties. Using its proprietary Enhanced Design and Combine (EDC) ...

more

Page 2 From 4
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE